Sawai Pharmaceutical Co., Ltd.

Sawai has highlighted its rival to Xarelto (rivaroxaban) orodispersible tablets among multiple new generics listings in Japan, lining up five new molecules across ten presentations that have just been

Bora Pharmaceuticals has completed its takeover of Minnesota-based Upsher-Smith Laboratories from Japanese former owner Sawai , with the deal opening up fresh opportunities for Bora as it eyes growth

Sawai Pharmaceutical has reported a slight growth in its net sales and core operating income in Japan compared to the last fiscal year in its financial third quarter, despite facing ongoing challenge

Astellas Pharma US Inc. ’s third-largest selling drug mirabegron, sold as Myrbetriq extended-release tablets, Betanis and Betmiga by the innovator, is set for competition in the US as Zydus Lifescien